Los Angeles, CA -- (SBWire) -- 04/11/2019 --Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

The classification of Dry Eye Drugs includes Artificial Tears, Anti-inflammatory drugs and other, and the proportion of Artificial Tears in 2017 is about 89%.

North America is the largest consumption place, with a consumption market share nearly 40% in 2017. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.

The global Dry Eye Drugs market was 5350 million US$ in 2018 and is expected to 11800 million US$ by the end of 2025, growing at a CAGR of 12.0% between 2019 and 2025.

This report studies the Dry Eye Drugs market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1071465/global-dry-eye-drugs-market

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Dry Eye Drugs in these regions, from 2014 to 2025, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

Allergan

Novartis AG

Valeant Pharmaceuticals

Santen Pharma

Shire

Johnson & Johnson

United Laboratories

Senju Pharmaceutical

Jianfeng Group

Eusan GMBH

By the product type, the market is primarily split into

Artificial Tears

Anti-inflammatory Drugs

Other

By the end users/application, this report covers the following segments

Hospital

Drug Stores

Online Pharmacies

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Rest of Middle East & Africa

Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/25028d503f7521687d8f34631e34361b,0,1,Global%20Dry%20Eye%20Drugs%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Manufacturers,%20Key%20Regions,%20Types%20and%20Application

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.